NYSE:BLCOMedical Equipment
Bausch + Lomb (NYSE:BLCO): Assessing Valuation After Q3 Revenue Growth and 2025 Guidance Update
Bausch + Lomb (NYSE:BLCO) released its third quarter earnings, reporting higher revenue than last year but also posting a net loss for the period. The company also updated its full-year 2025 revenue guidance.
See our latest analysis for Bausch + Lomb.
After a rough start this year, Bausch + Lomb’s recent 15.98% gain over the past 90 days signals that momentum may be shifting as investors digest stronger revenue and the latest guidance update. Still, with a 1-year total shareholder return of...